Previous Article | Next Article 
Journal of Virology, May 1999, p. 4171-4180, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Human Corneal Cells and Other Fibroblasts Can
Stimulate the Appearance of Herpes Simplex Virus from Quiescently
Infected PC12 Cells
Ying-Hsiu
Su,1
Rupalie L.
Meegalla,1
Rohini
Chowhan,1
Christopher
Cubitt,2
John E.
Oakes,2
Robert N.
Lausch,2
Nigel W.
Fraser,3 and
Timothy
M.
Block1,3,*
Department of Biochemistry and Molecular
Pharmacology, Jefferson Center for Biomedical Research of Thomas
Jefferson University, Doylestown,1 and
The Wistar Institute, Philadelphia,3
Pennsylvania, and Department of Microbiology and Immunology,
University of South Alabama, Mobile, Alabama2
Received 28 October 1998/Accepted 25 January 1999
 |
ABSTRACT |
A two-cell system for the stimulation of herpes simplex virus type
1 (HSV-1) from an in vitro model of long-term (quiescent) infection is
described. Rat pheochromocytoma (PC12) cells differentiated with nerve
growth factor were infected with HSV-1 strain 17. Little, if any,
cytotoxicity was observed, and a quiescent infection was established.
The long-term infection was characterized by the absence of all
detectable virus in the culture medium and little, if any, detectable
early or late viral-gene expression as determined by reverse
transcriptase PCR analysis. The presence of HSV-1 DNA was determined by
PCR analysis. This showed that approximately 180 viral genomes were
present in limiting dilutions where as few as 16 cells were examined.
The viral DNA was infectious, since cocultivation with human corneal
fibroblasts (HCF) or human corneal epithelial cells (HCE) resulted in
recovery of virus from most, if not all, clusters of PC12 cells.
Following cocultivation, viral antigens appeared first on PC12 cells
and then on neighboring inducing cells, as determined by
immunofluorescent staining, demonstrating that de novo viral protein
synthesis first occurred in the long-term-infected PC12 cells.
Interestingly, the ability to induce HSV varied among the cell lines
tested. For example, monkey kidney CV-1 cells and human hepatoblastoma
HepG2 cells, but not mouse neuroblastoma cells or undifferentiated PC12
cells, mediated stimulation. This work thus shows that (i) quiescent
HSV infections can be maintained in PC12 cells in vitro, (ii) HSV can
be induced from cells which do not accumulate significant levels of
latency-associated transcripts, and (iii) the activation of HSV gene
expression can be induced via neighboring cells. The ability of
adjacent cells to stimulate HSV gene expression in neuron-like cells
represents a novel area of study. The mechanism(s) whereby HCF, HCE,
and HepG2 and CV-1 cells communicate with PC12 cells and stimulate
viral replication, as well as how this system compares with other in
vitro models of long-term infection, is discussed.
 |
INTRODUCTION |
All herpesviruses establish latent
infections in their natural hosts. Following productive infection of
permissive cells at the periphery, herpes simplex virus type 1 (HSV-1),
for example, usually colonizes neurons of the peripheral nervous system
(reviewed in reference 40). The virus may, from time
to time and by unclear mechanisms, reactivate from latency and cause
productive infection at or near the site of initial entry into the host.
The molecular and cellular mechanisms involved in establishing,
maintaining, and mediating reactivation from latency are unclear. In
recent years, studies have centered on the role of latency-associated transcripts (LAT) in latency (1, 3, 10, 15, 22, 23, 29, 31, 32,
35, 42, 43, 45, 53). Since LAT are the only family of transcripts
detected by Northern blotting or conventional in situ hybridization in
the latently infected neurons, expression of the more than 70 genes of
HSV-1 is repressed (6, 9, 11, 14, 15, 46, 47). As many as
40,000 LAT copies may be present in each latently infected cell
(51). However, it was shown that there is a group of neurons
latently infected with HSV that have such low LAT levels that reverse
transcription-PCR (RT-PCR) amplification is necessary for detection
(38). Despite the convenience of LAT as a marker of latently
infected cells in mice and rabbits, the percent HSV DNA-containing
neurons in which abundant LAT have accumulated is 30% or less
(12, 13, 19, 21, 33, 34a). Thus, there appear to be at least
two populations of latently infected neurons with respect to LAT
levels: those with abundant LAT and those with few or no detectable
LAT. Although HSV mutants unable to produce LAT can reactivate, the reason that some, but not all, cells accumulate vast amounts of LAT and
whether subpopulations of cells unable to accumulate LAT are competent
to support reactivation, are not known. Most studies of latency and
reactivation are conducted in animal models. However, the small number
of neurons which harbor the viral genome, the complexity of the in vivo
setting, and ethical constraints place limits on animal studies. Thus,
an in vitro model which resembles natural latency is appealing. There
have been a number of reports of tissue culture models of latency
(20, 24, 41, 44, 50), some of which involve B lymphocytes or
fibroblasts as the host cells (24, 50). However, studies
with fibroblasts or lymphocytes may not be representative of
neuronal-cell viral latency seen following natural infection. Perhaps
the best-studied in vitro system is primary explant rat neonatal dorsal
root ganglia, which has been shown to be dependent on nerve growth
factor (NGF) for the maintenance of the latent viral state (44,
54, 55). However, preparation of dissected dorsal root ganglia is
inconvenient, and they contain heterogeneous groups of cells, including
support tissue as well as neurons. Furthermore, in all of the in vitro models mentioned above, either antiviral agents, such as acyclovir, nonpermissive temperatures, or low infectious doses were needed to
facilitate the establishment of latency.
We, therefore, further explored the possibility of using the rat
pheochromocytoma (PC12) tissue culture line as a model of long-term in
vitro HSV infections which might resemble in vivo latency or other
aspects of pathogenesis. In the presence of NGF, PC12 cells cease
division, extend long processes which have been shown to support action
potentials, and acquire many biochemical properties characteristic of
the peripheral nervous system (17, 18). We have previously
shown that HSV can establish a long-term infection of
NGF-differentiated PC12 cells which in some respects resembles in vivo
latency (2). In that system, while the level of virus in the
medium was low, it was not zero. This suggested an occurrence of either
a persistent infection or periodic reactivation. Moreover, reactivation
from the majority of cells in the population involved NGF deprivation
following the return of PC12 cells to a morphologically
undifferentiated state. The NGF-deprived PC12 cells were then destroyed
by HSV replication. Since reactivation of HSV from latently infected
neurons probably occurs in an environment where neurons do not lose
their differentiated phenotype, it was of interest to use the
long-term-infected PC12 system to define conditions resulting in a
complete absence of virus production. These conditions would then be
used to pursue alternative mechanisms of reactivation of the viral
genome. This article describes modifications of the PC12 cell system in
which HSV-1 infection resolves into completely quiescent infection with
respect to virus production.
Herpes simplex viruses are the leading cause of blindness among the
infectious agents in the United States (34a). Herpes eye
diseases may be the result of primary or recurrent infection (8,
52). In both cases, permissive corneal cells such as stromal
fibroblasts and epithelial cells play a role either in supporting viral
replication or in communicating with surrounding cells, perhaps
neurons. The role of interaction between permissive corneal cells and
latently infected neurons is uncertain.
In this report, a two-cell system of long-term infection from which HSV
can apparently be stimulated is described. "Long-term infection"
and "stimulation of virus" are used to describe this system instead
of "latency" and "reactivation" in order to avoid confusion or
overstatements. Long-term infection, as discussed here, can be achieved
in NGF-treated PC12 cells with a high infectious dose (a multiplicity
of infection [MOI] of 20), in the absence of antiviral agents, and at
an incubation temperature of 37°C. Two weeks after infection, there
was no detectable virus in the culture medium, and the cultures are
therefore called long-term infections. However, stimulation of HSV, as
defined by the appearance of infectious virus, could be induced by
cocultivation with primary human corneal fibroblasts (HCFs), or human
corneal epithelial cells (HCEs), and human hepatoblastoma cells
(HepG2). Monkey CV-1 cells, under appropriate conditions, could also
stimulate viral replication. However, mouse neuroblastoma (NA) or
undifferentiated PC12 cells were ineffective. To our knowledge, this is
the first report directly demonstrating a role of adjacent or
supporting cells in influencing HSV gene expression in neuron-like
cells. The possibility that information from some, but not all, types of permissive cells stimulates HSV gene activity in the
long-term-infected PC12 cells is discussed, and the way in which this
system compares to in vivo models and other in vitro models is considered.
 |
MATERIALS AND METHODS |
Virus and cells.
CV-1 cells (from the American Type Culture
Collection [ATCC]) were maintained in Eagle's minimal medium plus
5% calf serum. HepG2 cells were maintained in Dulbecco's modified
Eagle's medium supplemented with 10% fetal bovine serum. HSV-1 strain
17 was prepared in CV-1 cells. Virus titers were determined by a
standard plaque assay on a CV-1 monolayer under methylcellulose. PC12
cells from ATCC were grown in RPMI 1640 supplemented with 10%
heat-inactivated horse serum and 5% heat-inactivated fetal bovine
serum (PC12 medium). HCF and HCE cultures were prepared as previously
described (7). NA cells (a gift from Bernard Dietzshold,
Thomas Jefferson University) were maintained as described elsewhere
(50). The medium used in cocultivations was the medium used
for inducer cells.
Differentiation of PC12 cells.
To differentiate PC12 cells,
105 cells were seeded on poly-L-orinithine
(Sigma, St. Louis, Mo.)-coated 25-cm2 culture flasks. The
following day, cells were incubated in PC12 medium containing 100 ng of
2.5S NGF (Collaborative Biomedical Products, Bedford, Mass.)/ml for 1 week. Medium was replaced every 3 days. On day 7, 20 µM
fluorodeoxyuridine (FdUrd) (Sigma) was added for 2 to 3 days to
eliminate undifferentiated PC12 cells. Fresh NGF-supplemented medium
was supplied thereafter.
Establishment of long-term HSV-1 infection.
Differentiated
PC12 cultures were infected with HSV-1 strain 17 at an MOI of 20 (2 × 106 PFU/flask). Following a 1-h incubation at
37°C, cultures were treated with 3 ml of sodium citrate buffer (pH
3), modified as described elsewhere (4), for 30 s to 1 min to inactivate residual virus. Buffer was removed and flasks were
rinsed with PC12 medium once. After low-pH treatment, cultures were
incubated at 37°C with fresh medium containing NGF. To monitor for
the release of HSV-1 progeny, the culture medium was collected and
titered on CV-1 cells by a standard plaque assay.
RNA isolation and RT-PCR.
Total cellular RNA was isolated
from cell culture by using the Trizol reagent (Gibco-BRL, Rockville,
Md.). RNA was treated with DNase I (Boehringer Mannheim) to eliminate
DNA contamination. One microgram of RNA was denatured with glyoxal and
subjected to a 1% agarose gel for electrophoresis to determine the
quality of RNA. cDNA was synthesized from 0.5 µg of total RNA
isolated from each T25 flask in a total 20-µl volume with the
SuperScript Pre-amplification System (Gibco-BRL) according to the
manufacturer's instructions. PCR amplifications were carried out with
2.5 U of Taq polymerase (Fisher Scientific, Pittsburgh,
Pa.), primers, and 1 µl of cDNA in a 50-µl reaction volume. Primers
and internal oligonucleotide probes used in this study are listed in
Table 1. Amplifications consisted of 40 cycles of denaturation at 94°C for 1 min, annealing at 60°C for
45 s, and extension at 72°C for 1 min. PCR products were
resolved by electrophoresis through 1% agarose gels, visualized by
ethidium bromide staining, and then transferred onto a Genescreen
membrane (NEN Life Science Products, Boston, Mass.). The membranes were
hybridized with the specific probe of interest by using the Renaissance
CDP-Star Chemiluminescence detection system (NEN Life Science
Products).
Determination of the RT-PCR assay sensitivity.
To determine
the RT-PCR assay sensitivity for each primer set, PCR fragments of each
primer set were cloned into the pCR-Script cloning vector (Stratagene,
La Jolla, Calif.) according to the manufacturer's specifications. Each
clone was then transcribed by in vitro transcription (Promega, Madison,
Wis.) according to the manufacturer's specifications. RNA was
quantitated by spectrophotometry. Serial fivefold dilutions of a known
amount of RNA mixed with 0.5 µg of PC12 total RNA were reverse
transcribed by the first-strand cDNA synthesis system (Gibco-BRL),
followed by PCR amplification with specific primers. After 40 cycles of
amplification, the PCR product was resolved by agarose gel
electrophoresis, visualized by ethidium bromide staining, and then
transferred onto a Genescreen membrane (NEN Life Science Products). The
membranes were hybridized with a specific internal oligonucleotide
probe by using the Renaissance CDP-Star Chemiluminescence detection
system (NEN Life Science Products). The assay sensitivity was
determined as the highest dilution which yields a visible band after hybridization.
Quantification of HSV-1 genomes in long-term-infected PC12
culture.
One 25-cm2 flask of a PC12 culture with a
long-term HSV-1 infection was trypsinized, and cells were collected by
centrifugation, dispersed by passing through a 22-gauge needle three
times, and then counted by trypan blue exclusion. A series of 10-fold
dilutions of cells were prepared, treated with low pH (pH 2.4) as
described previously (30), and then subjected to 40 cycles
of PCR with a series of dilutions of known amounts of HSV-1 strain 17 DNA by using the primers specific for HSV-1 thymidine kinase (TK) gene.
The PCR products were then resolved by agarose gel electrophoresis, visualized by ethidium bromide staining, and photographed. The photograph was then scanned with a Hewlett-Packard Scanjet 3C, and the
band intensity was analyzed by using BioMax software (Kodak Scientific
Imaging System). The quantity of HSV-1 genome in long-term-infected cells was determined by comparing the intensity readings of
PCR-amplified bands.
Immunofluorescence and antibodies.
A total of
104 PC12 cells were seeded and differentiated on
poly-L-orithine-coated one-well chamber slides. A long-term
HSV-1 infection was established as described above. HepG2 cells were used to induce the quiescent viruses. To prevent virus spread from cell
to cell, methylcellulose medium was added 4 h after overlay. At
48 h after stimulation, the culture was rinsed twice with
phosphate-buffered saline (PBS) and then fixed with acetone-methanol (1:1) at
20°C for 10 min. After two washes with PBS and one wash with wash buffer (0.8% bovine serum albumin [BSA]-0.1% gelatin in
PBS), the slides were incubated with the blocking reagent (0.8% BSA-0.1% gelatin-5% goat serum in PBS) at room temperature for 20 min. This was followed by a 1:100 dilution of rabbit polyclonal antibodies to the extreme C terminus of neurofilament H (Chemicon International Inc., Temecula, Calif.) and Cy3-conjugated
affinity-purified anti-rabbit antibodies (Chemicon) with intervening
washing steps with wash buffer and PBS. Finally, slides were incubated
with a 1:50 dilution of fluorescein isothiocyanate (FITC)-conjugated polyclonal rabbit anti-HSV-1 and -2 antibody (Chemicon) and examined with a fluorescence microscope (Olympus BX-FLA system). The anti-HSV monoclonal antibody (MAb) 8D2 was prepared and purified as described previously (28). A 1:500 dilution of ascites fluid of MAb
8D2 was used; this dilution was shown by standard virus neutralization assays (28) to be sufficient to neutralize all 1,000 PFU of HSV in a reconstruction experiment in which 1,000 PFU of HSV were incubated with MAb.
 |
RESULTS |
Virus production following infection of NGF-treated PC12 cells as a
function of time.
PC12 cells were seeded onto
poly-L-ornithine coated flasks and differentiated with 100 ng of NGF/ml as described in Materials and Methods. One week later,
almost all (more than 99%) of the PC12 cells in the culture were
differentiated, on the basis of morphological evaluation (e.g., they
contained processes at least 2 cell diameters in length). Since, in
previous studies of NGF-differentiated cells (2), the
population of undifferentiated cells appeared to persist,
undifferentiated cells were eliminated from the cultures following 2 to
3 days of incubation in medium containing 20 µM 5-fluorodeoxyuridine.
Differentiated cultures were then infected at an MOI of 20 with HSV-1
strain 17. One hour after inoculation, cultures were rinsed with sodium
citrate, pH 3.0, to inactivate residual viruses. The efficiency of
inactivation by sodium citrate buffer was greater than 99%, as shown
in Table 2. After sodium citrate buffer
treatment, the infected NGF-differentiated PC12 cultures were
maintained continuously in NGF-supplemented medium. To monitor for
virus growth, medium was collected and assayed for infectious particles
on a CV-1 monolayer by a standard plaque assay. As shown in Fig.
1, in each of the five flasks examined, there was production of progeny virus, peaking and dropping at 2 to 3 days after infection, although the titer never exceeded 105
PFU per flask of 105 cells. Since each flask contains
105 cells, a low level of virus production could represent
very inefficient viral production from a minority of the population,
which tolerate synthesis and release of virus and then recover. Another
possibility is that an antimitotic agent did not completely eliminate
undifferentiated cells, and it is these cells which synthesize progeny
after viral infection and are eventually eliminated from the culture by
virus-induced cytopathic effect. In any event, following the initial
period of virus production, there is a complete lack of detectable
virus in the culture medium. This was true for each of the 25 flasks examined over more than three experiments. Cultures surviving infection
with HSV-1 are, at this point, designated as long-term or quiescently
infected cultures.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
HSV-1 production in NGF-treated PC12 cells as a function
of time following infection. PC12 cells maintained in five separate
flasks were differentiated with NGF and infected with HSV-1 as
described in Materials and Methods. At the indicated times after
infection, aliquots of medium were removed and the number of PFU was
determined by a standard plaque assay on monolayers of CV-1 cells. Each
value is presented as total PFU in each flask. Each dot represents the
results from a different flask. The dashed line represents the minimum
level of detection by the standard plaque assay, which is 40 PFU/flask.
|
|
HSV-1 DNA is detected in long-term-infected PC12 cultures.
To
investigate if the lack of virus production in long-term-infected
cultures was due to the disappearance of viral genomes from the
cultures, the presence of viral DNA was examined. Long-term HSV-infected PC12 cells were trypsinized, collected, passed through a
22-gauge needle three times, and counted. It was noticed that there
were still cell clusters in cell suspensions, even after passing
through the needle, which could be due to the aggregation of PC12 cells
after NGF treatment. By counting cells from three independent flasks,
it was determined that there was a range of 2 × 104
to 6 × 104 cells per flask, which were mostly within
clusters. PCR analysis with primers specific for the TK gene was
performed to quantify HSV genomes in limiting numbers of
long-term-infected cells. Serial fivefold dilutions of known amounts of
HSV-1 strain 17 DNA were used as a reference in the PCR analysis. As
shown in Fig. 2, in this experiment, HSV
DNA was detected in the dilutions containing as few as 16 cells per
reaction. As shown by densitometry, the amplification of 80 to 400 copies of HSV-1 genome was within the linear range. The intensity
reading of the ethidium bromide-stained band from 16 cells suggests
that the quantity of HSV-1 genomes is approximately 180 copies.
Therefore, 16 PC12 cells in long-term-infected cultures harbor a
minimum of 11 genomes per cell on average, and approximately 22,000 to
67,000 copies of the HSV-1 genome are present per culture flask.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 2.
Detection of HSV-1 DNA in long-term-infected PC12 cells.
A long-term-infected PC12 culture lacking detectable virus in the
medium was trypsinized. Cells were collected, passed through a 22-gauge
needle three times, counted, and diluted as indicated. Each cell
dilution was treated with sodium acetate (pH 2.2) and subjected to PCR
with the primer specific for the TK gene of HSV-1. A fivefold dilution
of a known amount of HSV-1 DNA was used under the same PCR condition to
estimate the number of HSV genomes in each reaction mixture as
described in Materials and Methods. A densitometric analysis of the gel
is given at the bottom.
|
|
HSV gene expression in long-term-infected cells.
The hallmark
of HSV latency is limited, if any, viral gene expression
(47). The LAT appear to be the only viral-gene products which accumulate abundantly in neurons derived from latently infected humans and animals (15), although low levels of non-LAT
viral gene expression have been observed by using extremely sensitive methods (26, 27). It was therefore of interest to determine which, if any, viral-gene products were present in long-term-infected PC12 cell cultures. RNA was isolated from long-term-infected PC12 cultures 2 weeks after infection, a time at which no virus was detected
in the culture medium (as determined by sampling at three separate
times). This was compared with RNA isolated from productively infected
NGF-differentiated PC12 cells 24 h after infection with HSV-1. The
expression of four key viral transcripts (alpha 27, TK, gC, and LAT)
representing the different kinetic classes was examined. Primers and
amplification schemes are described in Materials and Methods. Figure
3A shows the results of RT-PCR analysis
of RNA isolated from the long-term-infected cultures. Clearly, although viral RNA is detected in samples from productively infected PC12 cells
(Fig. 3A, lane F1), no HSV-1 transcripts were detected in samples from
long-term-infected cultures (lanes F2 through F4). That is, neither
alpha 27 transcripts, TK transcripts, gC transcripts, nor LAT had
accumulated in the long-term-infected PC12 cells even to levels
detectable by RT-PCR. Since glyceraldehyde-3-phosphate dehydrogenase (GAPDH) RNA is a constitutively produced cellular (host)
transcript, it was used to indicate the relative amount of RNA in each
sample. The relatively equal amounts of GAPDH RNA detected in each
sample suggest that similar amounts of RNA were present in each
experimental set. Also, the failure to detect a PCR product from any
samples when RT was omitted confirms that RNA and not DNA was being
detected in the samples. Parenthetically, viral transcripts could not
be detected in RNA derived from long-term-infected cultures, as
determined by Northern hybridization (data not shown).

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 3.
HSV-1 gene expression in long-term-infected PC12 cells.
Total RNA was extracted from HSV-1-infected PC12 culture as described
in Materials and Methods. A total of 0.5 µg of total RNA was reverse
transcribed (RT), and the cDNA was then subjected to a PCR with the
primers specific for HSV-1 alpha 27, TK, gC, and LAT genes as listed in
Table 1. After 40 cycles of amplification, PCR products were resolved
by agarose gel electrophoresis and visualized by ethidium bromide
staining (A). The gel was then transferred onto a membrane and
hybridized with specific probes as described in Materials and Methods.
(B) Chemiluminescence exposure of the Southern hybridization of PCR
products. Lanes F1 show the results obtained with cDNA from an
NGF-differentiated PC12 culture 24 h after infection with HSV-1
strain 17, with (+) and without ( ) RT. Lanes F2, F3, and F4, cDNAs
from three individual long-term HSV-1-infected flasks. (C) Assay
sensitivity of each primer after Southern hybridization of RT-PCR
products.
|
|
Since extremely low levels of viral-gene expression have been reported
to occur from various regions of the viral genome in
long-term-infected
cells (
26,
27), we explored the possibility
that HSV gene
expression occurred in the long-term-infected PC12
cells at levels
beneath the level of even direct RT-PCR detection.
The sensitivity of
transcript detection was thus enhanced approximately
100-fold by
Southern blot hybridization of the products of the
RT-PCR, immobilized
in membranes, with labeled probes. The primers
and specific internal
oligonucleotide probes used are listed in
Table
1 and described in
Materials and Methods, and the assay
sensitivity is shown in Fig.
3C.
Figure
3B shows that when this
sensitive assay was used to detect viral
transcripts, gC RNA,
a marker of late gene expression, could still not
be detected
in any samples of RNA from long-term-infected cultures.
However,
a minority of the long-term-infected cultures did appear to
contain
approximately 30,000 copies of alpha 27 (Fig.
3B, lane F3) and
1,200 copies of TK (Fig.
3B, lane F2) transcripts per flask. LAT
could
be detected in all three flasks containing long-term-infected
cells by
using this sensitive method of detection. These data
suggest that
viral-gene expression does occur in a limited way
in a minority of the
long-term-infected PC12 cell cultures, possibly
in subpopulations of
cells. The meaning of this is considered
in the
Discussion.
HCFs induce HSV from long-term-infected cultures.
Under
physiological settings of in vivo conditions, latently infected cells
are in intimate contact with other, noninfected cells. To test the
possibility that the HSV genome in long-term-infected PC12 cells could
be influenced and even stimulated ("reactivated") by neighboring
noninfected cells, a two-cell system was used. HCFs were chosen as the
inducer cells because they are sites of recurrent infection in the eyes
and are highly permissive both in vivo and in vitro. In addition, these
cells are in proximity to the axon processes of the peripheral ganglia,
which may harbor latent HSV genomes in vivo (34). Figure
4A and B show PC12 cells prior to and 10 days after NGF treatment, respectively. No cytopathic effect was
detectable in NGF-differentiated PC12 culture 13 days after HSV-1
strain 17 infection (Fig. 4C). In these experiments, NGF removal alone
did not induce the appearance of virus in the culture medium (see
Discussion). However, long-term-infected cultures that had been shown
to be devoid of infectious virus were overlaid with confluent
monolayers of primary HCFs (Fig. 4D). Curiously, HCFs appeared to move
under PC12 cells to form a monolayer, while the differentiated
morphology of PC12 remained. Figure 5
shows the dramatic virus growth following HCF overlay: although most flasks remained devoid of virus by day 2, infectious virus was recovered in the culture medium, with titers reaching 105
to 106 per flask by day 4. Therefore, long-term-infected
PC12 cells contain infection-competent HSV genomes which were
reactivated by an overlay of corneal fibroblasts.

View larger version (133K):
[in this window]
[in a new window]
|
FIG. 4.
Morphology of NGF-differentiated PC12 cells. A total of
105 undifferentiated PC12 cells were seeded onto a
poly-L-ornithine-coated flask (A). The next day, cells were
incubated in medium containing NGF for a week. On day 7, the
antimitotic agent FdUrd was added to the growth medium for an
additional 2 days to eliminate undifferentiated cells. (B)
NGF-differentiated PC12 cells 10 days after treatment and prior to
HSV-1 strain 17 infection. Thirteen days after infection, the culture
was overlaid with HCFs. (C and D) Long-term-infected PC12 culture
before and 1 day after HCF overlay, respectively.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 5.
Reactivation of HSV-1 in long-term-infected cultures.
NGF was removed from long-term HSV-1-infected PC12 cultures at the time
indicated by the arrow and then replaced with 5 ml of medium/flask or
overlaid with HCFs. Culture medium was collected daily to monitor for
virus content. There were three flasks for each group. The dashed line
represents the minimum level of detection by the standard plaque assay,
which is 40 PFU/flask.
|
|
The possibility that the ability of overlaying cells to mediate
stimulation was restricted in cell type was tested. Long-term-infected
cultures were overlaid on day 15 after HSV-1 infection with cells
of
the following lines: undifferentiated PC12, NA, HCF, HCE, CV-1,
or
HepG2. As expected, HCFs were able to stimulate virus 2 days
after
overlay, as shown in Table
3.
Interestingly, only CV-1
cells, HCEs, and HepG2 cells could mediate the
stimulation of
virus from long-term-infected cultures. No virus was
detectable
in culture media of PC12 cells overlaid with cells of the
neuronal
lineage (PC12 or NA cells) for 4 days after overlay. Moreover,
it is noted that, unlike the situation with HepG2 cells, the ability
of
CV-1 cells to mediate the stimulation of HSV from long-term-infected
cultures declined with the age of the long-term cultures. This
is
considered further in the Discussion.
The possibility that the virus stimulated from long-term-infected cells
was due to residual virus from the initial inoculum
or a persistent
infection was tested by determining if the stimulation
was reduced by
incubation with anti-HSV serum in order to neutralize
the virus
remaining in the medium of long-term cultures. Briefly,
3 days prior to
stimulation with HepG2 cells, long-term-infected
PC12 cells were
incubated with an amount of MAb 8D2 that could
neutralize 1,000 PFU of
HSV (see Materials and Methods) (
28).
HepG2 cells were then
added to the cultures, as usual, and the
amount of virus stimulated
from the long-term cultures was measured.
Stimulation of the
long-term-infected PC12 cultures by HepG2 cells
was not influenced by
the presence of the MAb to HSV in the culture
medium for a time prior
and up to the time of induction. This
suggests that the source of virus
infecting the HepG2 cells used
for induction was within PC12 cells (was
intracellular) and inaccessible
to the
MAb.
To test whether the failure of PC12 and NA cells to mediate
reactivation is due to a nonpermissiveness to viral replication,
the
single-step growth kinetics of HSV-1 strain 17 in PC12, NA,
CV-1, and
HepG2 cells were compared. Although HSV-1 strain 17
replication in NA,
CV-1, or HepG2 cells was comparable, PC12 cells
yielded 1 to 2 log
units less infectious-virus growth than the
others (data not shown).
Nevertheless, all these four cell lines
were permissive to HSV
replication. Thus, the failure of NA and
PC12 cells to induce
reactivation was not due to nonpermissiveness
to viral
replication.
In addition, the efficiency of plating (EOP) of HSV-1 strain 17 on each
of the relevant cell lines was tested. Briefly, 1,000-PFU
aliquots (as
defined by plaquing on CV-1 cells) were used to inoculate
flasks
containing 100,000 PC12, HepG2, NA, or CV-1 cells, and
the numbers of
infectious centers were determined by plating on
CV-1 monolayers. The
EOPs of HSV-1 were comparable for CV-1 and
HepG2 cells. The EOPs of
HSV-1 on NA and PC12 cells were 60 and
10%, respectively, relative to
CV-1 cells. These experiments were
performed in triplicate, at two
different times. Since each long-term-infected
PC12 cell flask
contained fewer than 40 PFU (Fig.
5), as assessed
on CV-1 cells, the
EOP data suggest that for residual HSV to have
infected and been
amplified in the PC12 cells used as stimulator
(Table
3), at least 400 PFU would have had to be
present.
The stimulation of HSV from long-term-infected cultures occurs
ubiquitously throughout the culture.
As previously stated,
following overlay with CV-1 cells or HCFs, long-term-infected cultures
produced infectious HSV (Table 3). Although medium from
long-term-infected cultures overlaid with inducer cells contained
substantial amounts of HSV, the virus in the culture medium was likely
to have included progeny from PC12 cells which were amplified in the
permissive indicator cells. Thus, it was not clear if the source of
virus infecting the indicator cells was many or few PC12 cells. To
distinguish between these possibilities, long-term-infected PC12 cells
were overlaid with CV-1 monolayers under plaquing conditions, in
methylcellulose medium, where diffusion of virus was very limited. Five
days after overlay, typical HSV-induced plaques were seen widely
distributed throughout the flasks. More than 500 plaques were counted,
with many merging zones of cytopathic effect. NGF-treated PC12 cells grew in clusters of 5 to 50 cells, and nearly every cluster was associated with a virus plaque.
Detection of induced HSV antigens on long-term-infected PC12 cells
following stimulation.
To more directly observe and locate HSV
antigens appearing after stimulation of long-term PC12 cells, dual
immunofluorescence staining was performed. PC12 cells were seeded and
differentiated onto chamber slides as described in Materials and
Methods. After long-term infection was established, HepG2 cells were
overlaid to stimulate quiescent viruses. Methylcellulose medium was
used to impede virus diffusion. Mock-infected NGF-differentiated PC12 cultures were also overlaid with HepG2 cells as a negative control for
HSV antigen. Two days after HepG2 overlay, slides were processed for
immunofluorescence staining by using antibodies to neurofilaments and
HSV antigens as described in Materials and Methods. The specificity of
anti-neurofilament antibodies was confirmed by showing binding to
NGF-differentiated PC12 cultures and not to HepG2 cells (data not
shown). Figure 6 shows immunofluorescence
staining of mock-infected (Fig. 6A through C) and long-term-infected
(Fig. 6D through F) PC12 cultures overlaid with HepG2 cells. Figure 6A,
B, and C all show the same field of mock-infected PC12 cells, and Fig.
6D, E, and F all show the same field of long-term-infected PC12 cells. The photographs in panels A and D were taken under the light
microscope, those in panels B and E were taken under the filter which
permits the visualization of red fluorescence (anti-neurofilament
staining) only, and those in panels C and F were taken under the filter for visualization of green fluorescence (anti-HSV antigen staining). As
shown in Fig. 6B, PC12 cells were positively stained by
anti-neurofilament antibodies, while HepG2 cells were negative. There
was no detectable HSV antigen on either PC12 or HepG2 cells or
mock-infected cultures, as shown in Fig. 6C. In contrast, after 2 days
of overlay with HepG2 cells, long-term-infected PC12 cells expressed
HSV antigens detected by FITC-conjugated polyclonal anti-HSV antibodies
(Fig. 6F). By counting the number of neurofilament-positive cells (to restrict the view to PC12-derived cells) which were also HSV antigen positive, it is estimated that at least 70% of the long-term PC12 cell
clusters harbored quiescent HSV which had been stimulated. These data
demonstrate that (i) infectious HSV detected in the stimulated culture
medium (Fig. 5) originates from the long-term-infected PC12 cells and
(ii) as implied elsewhere, almost all PC12 cells in the
long-term-infected cultures harbor HSV.


View larger version (75K):
[in this window]
[in a new window]
|
FIG. 6.
Immunofluorescence staining of HSV-1 antigens on
long-term-infected PC12 cells following reactivation.
NGF-differentiated PC12 cultures were prepared in chamber slides. The
cultures were infected with HSV-1 strain 17 at an MOI of 20 (D through
F) or mock infected (A through C). Twenty-two days after infection, the
cultures were overlaid with HepG2 cells in methylcellulose medium to
stimulate quiescent viruses. Two days later, the cultures were fixed
and stained with anti-neurofilament (red) and anti-HSV (green)
antibodies. Panels A, B, and C all show the same field of the
mock-infected culture. Panels D, E, and F all show the same field of
the long-term-infected culture. The photographs in panels A and D were
taken under the light microscope, those in panels B and E were taken
under the filter visualizing red fluorescence, and those in panels C
and F were taken under the filter in which green fluorescence only was
visualized. Arrows point to the stained PC12 cells.
|
|
 |
DISCUSSION |
HSV reactivation from latent infection normally occurs from
neurons in a complex in vivo physiological setting in which multiple cell types interact. In this report, we describe a novel two-cell system for the stimulation of HSV from an in vitro infection in which
the virus is quiescent with regard to production of infectious virus.
The quiescently infected PC12 cells are called long-term-infected rather than latent cultures in order to avoid confusion with in vivo
latency. However, in the long-term-infected cultures described here,
there is extremely limited, if any, viral-gene expression. Moreover,
the viral genome can be induced by cocultivation with specific cells.
PC12 cells were differentiated with NGF and infected with HSV-1 strain
17. After an initial period in which low-level viral replication
occurred (Fig. 1), possibly in a minority of cells, a quiescent
infection was established. Northern hybridization and RT-PCR failed to
detect any HSV-1 transcripts (including LAT) from RNA derived from
long-term-infected PC12 cells. This was surprising because LAT have
been shown to accumulate in the nuclei of neurons derived from latently
infected animals in great abundance, up to 40,000 copies per neuron
(51). However, PC12 cells in the long-term-infected cultures
did accumulate low levels of LAT, as determined by Southern blot
hybridization of the RT-PCR products (Fig. 3). Thus, by using methods
that could detect as few as 200 RNA molecules per reaction, it appears
that all long-term-infected cultures tested contained a minority of
PC12 cells that were harboring LAT. This level of LAT was too low to be
detected by Northern blot hybridization or direct RT-PCR. Although LAT
were synthesized following productive infection of NGF-treated PC12
cells, the amount of LAT detected was at least 10 times less than that
seen in samples derived from productive infection of undifferentiated PC12 cells (data not shown). Thus, it may also be that LAT stability, accumulation, or synthesis, is different in undifferentiated, NGF-differentiated, and latently infected cells. In this regard, we
note that the accumulation of LAT is dependent upon alternative splicing and the failure of the host cell to efficiently debranch the
LAT lariat (39, 56). Perhaps long-term-infected PC12 cells have sufficient levels of debranching enzyme to eliminate LAT.
The immediate-early gene alpha 27 and the early tk gene were
also detected by Southern blot hybridization to RT-PCR products in a
minority of the flasks containing long-term-infected cultures. Transcripts of the late gC gene were not detected in any
long-term-infected cultures (Fig. 3). Since there were no detectable gC
transcripts and spontaneous release of infectious particles, as
measured by plaque assay, did not occur, it is unlikely that the alpha
27 or TK transcripts were from "smoldering" infections. It is
possible that, occasionally, abortive viral replication occurs in
subpopulations. Perhaps abortive reactivations occur during in vivo
latent infection (27). This is under investigation.
The presence of LAT is associated with latency in vivo (9,
15), but abundant LAT are actually not present in most latently infected cells (51). There appear to be at least two
populations of latently infected neurons in vivo: (i) those with
abundant LAT and (ii) those with few or no detectable LAT. Therefore,
it appears that the PC12 long-term infections described in this report are more representative of the subpopulation of latently infected cells
which have no detectable LAT or very low levels of LAT.
In spite of the fact that mutant viruses unable to synthesize LAT can
reactivate, whether the subpopulation of cells in vivo which are LAT
negative, or have very low levels of LAT, can support reactivation
remains an open question. We demonstrate here that long-term-infected
PC12 cells which harbor few or no LAT can support the stimulation and
release of HSV.
NGF deprivation alone did not induce virus appearance in
long-term-infected cultures described in this report (data not shown). In a previous report, for example, NGF deprivation alone was sufficient to cause the dedifferentiation of PC12 cells and the appearance of
virus in the culture medium (2). In that report, there was evidence that the viral genome was not completely quiescent, since low
levels of infectious virus could be detected in the culture medium of
the long-term-infected cells. It is possible that the reactivation
observed before was a combination of stimulation from latently infected
cells and reinfection of dedifferentiated PC12 cells. However, in the
system described here, there is no detectable virus in the
long-term-infected culture medium. Perhaps all undifferentiated PC12
cells were eliminated by the antimitotic agent FdUrd.
It is possible that the source of virus infecting the CV-1 cells, HepG2
cells, or HCFs (see Fig. 5) was residual virus persisting in the
culture medium or cell membranes of long-term-infected cells and not a
stimulation event induced by the overlaying cells. This possibility is
considered unlikely because (i) HSV antigens were detected only on
anti-neurofilament-stained PC12 cells after 48 h after induction
by a HepG2 cell overlay in the methylcellulose medium (Fig. 6); (ii)
infectious virus was not recovered for more than 2 days following
cocultivation with inducer cells (had there been residual virus in the
long-term-infected cultures, progeny would have been detected within 1 day following cocultivation with permissive CV-1 or HepG2 cells); (iii)
when amounts of an HSV-specific MAb sufficient to neutralize 1,000 PFU
of HSV per flask were included in the culture medium prior to
stimulation with HepG2 cells, they did not prevent HepG2 cell
induction; and (iv) finally, although HepG2 cells could induce
stimulation of virus from long-term cultures regardless of the length
of time in culture, the ability of CV-1 cells to induce virus declined to zero 20 days after primary infection. Thus, since the EOP of HSV-1
on CV-1 cells was similar to that on HepG2 cells, if residual virus was
responsible for the stimulation achieved by HepG2 cells after 20 days
of long-term culture, CV-1 cells would also have been effective
stimulators, since they would also have been targets of residual virus infection.
The mechanism whereby human corneal cells, HepG2 cells, or CV-1 cells
induce the stimulation of HSV from the quiescently infected cultures is
unclear. The inducer cells could produce a soluble factor (a hormone or
neurotransmitter) which stimulates the viral genome in the
long-term-infected PC12 cells. Experiments to test this hypothesis are
under way. Another possibility is that cell adhesion molecules or other
plasma membrane molecules on the inducer cells interact directly with
NGF-treated PC12 cell membranes or cell matrix structures to
communicate a signal which stimulates viral-gene activation. In any
case, HSV stimulation did not require that PC12 cells dedifferentiate
and lose their neuron-like morphology. This is an important distinction
from our previous work, in which reactivation occurred predominantly
from dedifferentiated PC12 cells, following NGF removal. Stimulation
was also independent of the presence or absence of NGF, although NGF
could apparently depress stimulation kinetics (data not shown). In
addition, cell manipulation alone, such as trypsinization of
long-term-infected PC12 cells and overlaying long-term-infected PC12
cells on the monolayer of CV-1 cells, did not induce the appearance of
virus in the culture medium.
Thus, although more work clearly needs to be done to determine the
extent to which the PC12 cell system can predict features of in vivo
HSV latency, the availability of a tissue culture model in which
viral-gene expression can be induced by activator cells provides an
attractive means to study, at a minimum, how one cell can elicit viral
gene expression in another.
 |
ACKNOWLEDGMENTS |
This research was supported by NIH grant NS33768-11.
We thank Robert Jordan, Richard Gesser, Bruce Randazzo, and Ruth
Tal-Singer for discussion of this work; Mike Moxley for excellent technical assistance; and Mitra Dadmarz for reading the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Rm. 238, Jefferson Center for Biomedical Research of Thomas Jefferson
University, 700 E. Butler Ave., Doylestown, PA 18901-2697. Phone: (215)
489-4948. Fax: (215) 489-4920. E-mail:
block{at}lac.jci.tju.edu.
 |
REFERENCES |
| 1.
|
Block, T.,
J. Masonis,
J. Maggioncalda,
S. J. Deshmane, and N. W. Fraser.
1993.
A herpes simplex virus LAT minus mutant that makes small plaques on confluent CV-1 cells.
Virology
192:618-630[Medline].
|
| 2.
|
Block, T.,
S. Barney,
J. Masonis,
J. Maggioncalda,
S. Rattan,
T. Valyi-Nagy, and N. W. Fraser.
1994.
Long-term herpes simplex virus infections of nerve growth factor-differentiated PC12 cells.
J. Gen. Virol.
75:2481-2487[Abstract/Free Full Text].
|
| 3.
|
Block, T. M.,
J. G. Spivack,
I. Steiner,
S. Deshmane,
M. T. McIntosh,
R. P. Lirette, and N. W. Fraser.
1990.
A herpes simplex virus type 1 latency-associated transcript mutant reactivates with normal kinetics from latent infection.
J. Virol.
64:3417-3426[Abstract/Free Full Text].
|
| 4.
|
Cai, W.,
S. Person,
C. Debroy, and B. Gu.
1988.
Functional regions and structural features of the gB glycoprotein of herpes simplex virus type 1.
J. Mol. Biol.
201:575-588[Medline].
|
| 5.
|
Cook, M. L.,
V. B. Bastone, and J. G. Stevens.
1974.
Evidence that neurons harbor latent herpes simplex virus.
Infect. Immun.
9:946-951[Abstract/Free Full Text].
|
| 6.
|
Croen, K. D.,
J. M. Ostrove,
L. J. Dragovic,
J. E. Smialek, and S. E. Straus.
1988.
Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate-early gene "anti-sense" transcript by in situ hybridization.
N. Engl. J. Med.
317:1427-1432[Abstract].
|
| 7.
|
Cubbit, C. L.,
R. N. Lausch, and J. E. Oakes.
1994.
Differential regulation of granulocyte-macrophage colony-stimulating factor gene expression in human corneal cells by pro-inflammatory cytokines.
J. Immunol.
153:232-240[Abstract].
|
| 8.
|
Dawson, C. R., and B. Togni.
1976.
Herpes simplex eye infections: clinical manifestations, pathogenesis and management.
Surv. Ophthalmol.
21:121[Medline].
|
| 9.
|
Deatly, A. M.,
J. G. Spivack,
E. Lavi, and N. W. Fraser.
1987.
RNA from an immediate early region of the HSV-1 genome is present in the trigeminal ganglia of latently infected mice.
Proc. Natl. Acad. Sci. USA
84:3204-3208[Abstract/Free Full Text].
|
| 10.
|
Deshmane, S. L.,
M. Nicosia,
T. Valyi-Nagy,
L. T. Feldman,
A. Dillner, and N. W. Fraser.
1993.
An HSV-1 mutant lacking the LAT TATA element reactivated normally in explant cocultivation.
Virology
196:868-872[Medline].
|
| 11.
|
Devi-Rao, G. B.,
D. C. Bloom,
J. G. Stevens, and E. K. Wagner.
1994.
Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia.
J. Virol.
68:1271-1282[Abstract/Free Full Text].
|
| 12.
|
Ecob-Prince, M. S.,
K. Hassan,
M. T. Denheen, and C. M. Preston.
1995.
Expression of beta-galactosidase in neurons of dorsal root ganglia which are latently infected with herpes simplex virus type 1.
J. Gen. Virol.
76:1527-1532[Abstract/Free Full Text].
|
| 13.
|
Ecob-Prince, M. S.,
F. J. Rixon,
C. M. Preston,
K. Hassan, and P. G. E. Kennedy.
1993.
Reactivation in vivo and in vitro of herpes simplex virus from mouse dorsal root ganglia which contain different levels of latency-associated transcripts.
J. Gen. Virol.
74:446-455.
|
| 14.
|
Feldman, L. T.
1994.
Transcription of the HSV-1 genome in neurons in vivo.
Semin. Virol.
5:207-212.
|
| 15.
|
Fraser, N. W.,
T. M. Block, and J. G. Spivack.
1992.
The latency-associated transcripts of herpes simplex virus: RNA in search of function.
Virology
191:1-8[Medline].
|
| 16.
|
Frazier, D. P.,
D. Cox,
E. M. Godshalk, and P. A. Schaffer.
1996.
The herpes simplex virus type 1 latency-associated transcript promoter is activated through Ras and Raf by nerve growth factor and sodium butyrate in PC12 cells.
J. Virol.
70:7424-7432[Abstract].
|
| 17.
|
Greene, L. A., and A. Rukenstein.
1989.
The quantitative bioassay of nerve growth factor with PC12 cells, p. 139-147.
In
R. A. Rush (ed.), Nerve growth factors. John Wiley, New York, N.Y.
|
| 18.
|
Greene, L. A., and A. S. Tischler.
1976.
Establishment of a nonadrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.
Proc. Natl. Acad. Sci. USA
73:2424-2428[Abstract/Free Full Text].
|
| 19.
|
Gressens, P., and J. R. Martin.
1994.
In situ polymerase chain reaction: localization of HSV-2 DNA sequences in infections of the nervous system.
J. Virol. Methods
46:61-83[Medline].
|
| 20.
|
Harris, R. A., and C. M. Preston.
1991.
Establishment of latency in vitro by the herpes simplex virus type 1 mutant
In
1814. J. Gen. Virol. 72:907-913.
|
| 21.
|
Hill, J. M.,
B. M. Gebhardt,
R. J. Wen,
A. M. Bouterie,
H. W. Thompson,
R. J. O'Callaghan,
W. P. Halford, and H. E. Kaufman.
1996.
Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency.
J. Virol.
70:3137-3141[Abstract].
|
| 22.
|
Hill, J. M.,
J. B. Maggioncalda,
H. H. Garza,
Y.-H. Su,
N. W. Fraser, and T. M. Block.
1996.
In vivo epinephrine reactivation of ocular herpes simplex virus type 1 in the rabbit is correlated to a 370-base pair region located between the promoter and the 5' end of the 2.0-kilobase latency-associated transcript.
J. Virol.
70:7270-7274[Abstract/Free Full Text].
|
| 23.
|
Ho, D. Y., and E. S. Mocarski.
1989.
Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse.
Proc. Natl. Acad. Sci. USA
86:7596-7600[Abstract/Free Full Text].
|
| 24.
|
Jamieson, D. R. S.,
L. H. Robinson,
J. I. Daksis,
M. J. Nicholl, and C. M. Preston.
1995.
Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus type 1 Vmw65 mutants.
J. Gen. Virol.
76:1417-1431[Abstract/Free Full Text].
|
| 25.
|
Kosz-Vnenchak, M.,
J. Jacobson,
D. M. Coen, and D. M. Knipe.
1993.
Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons.
J. Virol.
67:5383-5393[Abstract/Free Full Text].
|
| 26.
|
Kramer, M. F., and D. M. Coen.
1995.
Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus.
J. Virol.
69:1389-1399[Abstract].
|
| 27.
|
Kramer, M. F.,
S.-H. Chen,
D. M. Knipe, and D. M. Coen.
1998.
Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus.
J. Virol.
72:1177-1185[Abstract/Free Full Text].
|
| 28.
|
Lausch, R. N.,
J. E. Oakes,
J. F. Metcalf,
J. M. Scimeca,
L. A. Smith, and S. M. Robertson.
1989.
Quantitation of purified monoclonal antibody needed to prevent HSV-1-induced stromal keratitis in mice.
Curr. Eye Res.
8:499-506[Medline].
|
| 29.
|
Leib, D. A.,
C. L. Bogard,
M. Kosz-Vnenchak,
K. A. Hicks,
D. M. Coen,
D. M. Knipe, and P. A. Schaffer.
1989.
A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency.
J. Virol.
63:2893-2900[Abstract/Free Full Text].
|
| 30.
|
Lu, X.,
T. M. Block, and W. H. Gerlich.
1996.
Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line.
J. Virol.
70:2277-2285[Abstract].
|
| 31.
|
Maggioncalda, J.,
A. Mehta,
N. W. Fraser, and T. M. Block.
1994.
Analysis of a herpes simplex virus type 1 LAT mutant with a deletion between the putative promoter and the 5' end of the 2.0-kilobase transcript.
J. Virol.
68:7816-7824[Abstract/Free Full Text].
|
| 32.
|
Mehta, A.,
J. Maggioncalda,
O. Bagasra, and T. M. Block.
1994.
A PCR DNA hybridization method to detect HSV-1 DNA neuronal cells, in situ, derived from latently infected people.
J. Anal. Morphol.
1:110-115.
|
| 33.
|
Mehta, A.,
J. Maggioncalda,
O. Bagasra,
S. Thikkavarapu,
P. Saikumari,
T. Valyi-Nagy,
N. W. Fraser, and T. M. Block.
1995.
In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice.
Virology
206:633-640[Medline].
|
| 34.
|
Mitchell, W. J.,
P. Gressens,
J. R. Martin, and R. DeSanto.
1994.
Herpes simplex virus type 1 DNA persistence, progressive disease and transgenic immediate early gene promoter activity in chronic corneal infections in mice.
J. Gen. Virol.
75:1201-1210[Abstract/Free Full Text].
|
| 34a.
|
National Eye Advisory Council.
1994.
Vision research a national plan, 1994-1998. NIH publication 93-3186.
National Institutes of Health, Bethesda, Md.
|
| 35.
|
Perng, G.-C.,
H. Ghiasi,
S. Slanina,
A. B. Nesburn, and S. L. Wechsler.
1996.
The spontaneous reactivation function of the herpes simplex virus type 1 LAT genes resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript.
J. Virol.
70:976-984[Abstract].
|
| 36.
|
Ramakrishnan, R.,
D. J. Fink,
G. Jiang,
G. P. Desai,
J. Glorioso, and M. Levine.
1994.
Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain.
J. Virol.
68:1864-1873[Abstract/Free Full Text].
|
| 37.
|
Ramakrishnan, R.,
M. Levine, and D. J. Fink.
1994.
PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant.
J. Virol.
68:7083-7091[Abstract/Free Full Text].
|
| 38.
|
Ramakrishnan, R.,
P. L. Poliani,
M. Levine,
J. C. Glorioso, and D. J. Fink.
1996.
Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR.
J. Virol.
70:6519-6523[Abstract].
|
| 39.
|
Rødahl, E., and L. Haarr.
1997.
Analysis of the 2-kilobase latency-associated transcript expressed in PC12 cells productively infected with herpes simplex virus type 1: evidence for a stable, nonlinear structure.
J. Virol.
71:1703-1707[Abstract].
|
| 40.
|
Roizman, B., and A. E. Sears.
1996.
Herpes simplex viruses and their replication, p. 2231-2296.
In
B. N. Fields, and D. M. Knipe (ed.), Fundamental virology. Raven Press, Ltd., New York, N.Y.
|
| 41.
|
Russell, J., and C. M. Preston.
1986.
An in vitro latency system for herpes simplex virus type 2.
J. Gen. Virol.
67:397-403[Abstract/Free Full Text].
|
| 42.
|
Sawtell, N., and R. L. Thompson.
1992.
Herpes simplex virus latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency.
J. Virol.
66:2157-2169[Abstract/Free Full Text].
|
| 43.
|
Sedarati, F.,
K. M. Izumi,
E. K. Wagner, and J. G. Stevens.
1989.
Herpes simplex virus type 1 latency-associated transcription plays no role in establishment of maintenance of a latency infection in murine sensory neurons.
J. Virol.
63:4455-4458[Abstract/Free Full Text].
|
| 44.
|
Smith, R. L.,
J. M. Escudero, and C. L. Wilcox.
1994.
Regulation of the herpes simplex virus latency-associated transcripts during establishment of latency in sensory neurons in vitro.
Virology
202:49-60[Medline].
|
| 45.
|
Steiner, I.,
J. G. Spivack,
R. P. Lirette,
S. M. Brown,
A. R. Maclean,
J. Subak-Sharpe, and N. W. Fraser.
1989.
Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection.
EMBO J.
8:505-511[Medline].
|
| 46.
|
Stevens, J. G.
1989.
Human herpesviruses: a consideration of the latent state.
Microbiol. Rev.
53:318-332[Free Full Text].
|
| 47.
|
Stevens, J. G.,
E. K. Wagner,
G. B. Devi-Rao,
M. L. Cook, and L. T. Feldman.
1987.
RNA complementary to a herpes virus gene mRNA is prominent in latently infected neurons.
Science
235:1056-1059[Abstract/Free Full Text].
|
| 48.
|
Tal-Singer, R.,
T. M. Lasner,
W. Podrzucki,
A. Skokotas,
J. J. Leary,
S. L. Berger, and N. W. Fraser.
1997.
Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures.
J. Virol.
71:5268-5276[Abstract].
|
| 49.
|
Thiele, K.,
S. Mittnacht, and H. Kirchner.
1989.
Persistent replication of herpes simplex virus type 1 in JOK-1 cells.
J. Gen. Virol.
70:1907-1911[Abstract/Free Full Text].
|
| 50.
|
Vahlne, A., and E. Lycke.
1978.
Herpes simplex virus infection on in vitro cultured neuronal (mouse neuroblastoma C1300) cells.
J. Gen. Virol.
39:321-332[Abstract/Free Full Text].
|
| 51.
|
Wagner, E. K., and D. C. Bloom.
1997.
Experimental investigation of herpes simplex virus latency.
Clin. Microbiol. Rev.
10:419-443[Abstract].
|
| 52.
|
Wander, A. H.,
Y. M. Centifanto, and H. E. Kaufman.
1980.
Strain specificity of clinical isolates of herpes simplex virus.
Arch. Ophthalmol.
98:1458-1467[Abstract/Free Full Text].
|
| 53.
|
Wigdahl, B. L.,
R. J. Ziegler,
M. Sneve, and F. Rapp.
1983.
Herpes simplex virus latency and reactivation in isolated rat sensory neurons.
Virology
127:159-167[Medline].
|
| 54.
|
Wilcox, C. L., and E. M. Johnson.
1988.
Characterization of nerve growth factor-dependent latency in neurons in vitro.
J. Virol.
62:393-399[Abstract/Free Full Text].
|
| 55.
|
Wilcox, C. L.,
R. L. Smith,
C. R. Freed, and E. M. Johnson, Jr.
1990.
Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro.
J. Neurosci.
10:1268-1275[Abstract].
|
| 56.
|
Wu, T.-T.,
Y.-H. Su,
T. M. Block, and J. M. Taylor.
1996.
Evidence that two latency-associated transcripts of herpes simplex virus type 1 are nonlinear.
J. Virol.
70:5962-5967[Abstract].
|
Journal of Virology, May 1999, p. 4171-4180, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Preston, C. M., Nicholl, M. J.
(2008). Induction of Cellular Stress Overcomes the Requirement of Herpes Simplex Virus Type 1 for Immediate-Early Protein ICP0 and Reactivates Expression from Quiescent Viral Genomes. J. Virol.
82: 11775-11783
[Abstract]
[Full Text]
-
McMahon, R., Walsh, D.
(2008). Efficient Quiescent Infection of Normal Human Diploid Fibroblasts with Wild-Type Herpes Simplex Virus Type 1. J. Virol.
82: 10218-10230
[Abstract]
[Full Text]
-
Miller, C. S., Danaher, R. J., Jacob, R. J.
(2006). ICP0 Is Not Required for Efficient Stress-Induced Reactivation of Herpes Simplex Virus Type 1 from Cultured Quiescently Infected Neuronal Cells.. J. Virol.
80: 3360-3368
[Abstract]
[Full Text]
-
Ng, A. K., Block, T. M., Aiamkitsumrit, B., Wang, M., Clementi, E., Wu, T.-T., Taylor, J. M., Su, Y.-H.
(2004). Construction of a Herpes Simplex Virus Type 1 Mutant with Only a Three-Nucleotide Change in the Branchpoint Region of the Latency-Associated Transcript (LAT) and the Stability of Its Two-Kilobase LAT Intron. J. Virol.
78: 12097-12106
[Abstract]
[Full Text]
-
Su, Y.-H., Moxley, M. J., Ng, A. K., Lin, J., Jordan, R., Fraser, N. W., Block, T. M.
(2002). Stability and circularization of herpes simplex virus type 1 genomes in quiescently infected PC12 cultures. J. Gen. Virol.
83: 2943-2950
[Abstract]
[Full Text]
-
Moxley, M. J., Block, T. M., Liu, H.-C., Fraser, N. W., Perng, G.-C., Wechsler, S. L., Su, Y.-H.
(2002). Herpes simplex virus type 1 infection prevents detachment of nerve growth factor-differentiated PC12 cells in culture. J. Gen. Virol.
83: 1591-1600
[Abstract]
[Full Text]
-
Hsu, W.-L., Everett, R. D.
(2001). Human Neuron-Committed Teratocarcinoma NT2 Cell Line Has Abnormal ND10 Structures and Is Poorly Infected by Herpes Simplex Virus Type 1. J. Virol.
75: 3819-3831
[Abstract]
[Full Text]
-
Arthur, J. L., Scarpini, C. G., Connor, V., Lachmann, R. H., Tolkovsky, A. M., Efstathiou, S.
(2001). Herpes Simplex Virus Type 1 Promoter Activity during Latency Establishment, Maintenance, and Reactivation in Primary Dorsal Root Neurons In Vitro. J. Virol.
75: 3885-3895
[Abstract]
[Full Text]
-
Lu, R., Misra, V.
(2000). Potential Role for Luman, the Cellular Homologue of Herpes Simplex Virus VP16 (alpha Gene trans-Inducing Factor), in Herpesvirus Latency. J. Virol.
74: 934-943
[Abstract]
[Full Text]